O Jimenez1, S Colli2, M Garcia Lombardi3, M V Preciado1, E De Matteo1,2, P Chabay4. 1. Molecular Biology Laboratory, Pathology Divison, Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), CONICET-GCBA, Hospital de Niños R. Gutiérrez, Gallo 1330, C1425EFD, Buenos Aires, Argentina. 2. Pathology Division, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina. 3. Oncology Division, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina. 4. Molecular Biology Laboratory, Pathology Divison, Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), CONICET-GCBA, Hospital de Niños R. Gutiérrez, Gallo 1330, C1425EFD, Buenos Aires, Argentina. paola_chabay@yahoo.com.ar.
Abstract
BACKGROUND: Classic Hodgkin lymphoma (cHL) is a lymphoid malignancy in which the microenvironment, where the neoplastic cells are immersed, contributes to the lymphomagenesis process. Epstein-Barr virus (EBV) presence also influences cHL microenvironment composition and contributes to pathogenesis. An increase in PDL1 expression in tumor cells and at the microenvironment was demonstrated in adult cHL. Therefore, our aim was to assess PD1/PDL1 pathway and EBV influence on this pathway in pediatric cHL, given that in Argentina, our group proved a higher incidence of EBV-associated pediatric lymphoma in children. METHODS: For that purpose, EBV presence was assessed by in situ hybridization, whereas PD1 and PDL1 expressions were studied by immunohistochemistry. PDL1 genetic alterations were analyzed by FISH, and survival was evaluated for PD1 and PDL1 expressions. RESULTS: EBV presence demonstrated no influence neither on PD1 expression at the microenvironment nor on PDL1 expression at HRS tumor cells. Unexpectedly, only 38% pediatric cHL displayed PDL1 genetic alterations by FISH, and no difference was observed regarding EBV presence. However, in EBV-related cHL cases, a higher number of PDL1 + cells were detected at the microenvironment. CONCLUSION: Even though a high cytotoxic environment was previously described in EBV-related pediatric cHL, it might be counterbalanced by an immunoregulatory micro-environmental PDL1 + niche. This regulation may render a cytotoxic milieu that unsuccessfully try to eliminate EBV + Hodgkin Reed Sternberg tumor cells in pediatric patients.
BACKGROUND:Classic Hodgkin lymphoma (cHL) is a lymphoid malignancy in which the microenvironment, where the neoplastic cells are immersed, contributes to the lymphomagenesis process. Epstein-Barr virus (EBV) presence also influences cHL microenvironment composition and contributes to pathogenesis. An increase in PDL1 expression in tumor cells and at the microenvironment was demonstrated in adult cHL. Therefore, our aim was to assess PD1/PDL1 pathway and EBV influence on this pathway in pediatric cHL, given that in Argentina, our group proved a higher incidence of EBV-associated pediatric lymphoma in children. METHODS: For that purpose, EBV presence was assessed by in situ hybridization, whereas PD1 and PDL1 expressions were studied by immunohistochemistry. PDL1 genetic alterations were analyzed by FISH, and survival was evaluated for PD1 and PDL1 expressions. RESULTS:EBV presence demonstrated no influence neither on PD1 expression at the microenvironment nor on PDL1 expression at HRS tumor cells. Unexpectedly, only 38% pediatric cHL displayed PDL1 genetic alterations by FISH, and no difference was observed regarding EBV presence. However, in EBV-related cHL cases, a higher number of PDL1 + cells were detected at the microenvironment. CONCLUSION: Even though a high cytotoxic environment was previously described in EBV-related pediatric cHL, it might be counterbalanced by an immunoregulatory micro-environmental PDL1 + niche. This regulation may render a cytotoxic milieu that unsuccessfully try to eliminate EBV + Hodgkin Reed Sternberg tumor cells in pediatric patients.
Authors: Yuxuan Liu; Ahmad Sattarzadeh; Arjan Diepstra; Lydia Visser; Anke van den Berg Journal: Semin Cancer Biol Date: 2013-07-15 Impact factor: 15.707
Authors: Mahdi Nohtani; Katerina Vrzalikova; Maha Ibrahim; Judith E Powell; Éanna Fennell; Susan Morgan; Richard Grundy; Keith McCarthy; Sarah Dewberry; Jan Bouchal; Katerina Bouchalova; Pamela Kearns; Paul G Murray Journal: Cancers (Basel) Date: 2022-09-01 Impact factor: 6.575
Authors: Oscar Jimenez; Tamara Mangiaterra; Sandra Colli; Mercedes García Lombardi; Maria Victoria Preciado; Elena De Matteo; Paola Chabay Journal: Front Oncol Date: 2022-08-05 Impact factor: 5.738
Authors: Eline A M Zijtregtop; Ilse Tromp; Rana Dandis; Christian M Zwaan; King H Lam; Friederike A G Meyer-Wentrup; Auke Beishuizen Journal: Pathol Oncol Res Date: 2022-08-11 Impact factor: 2.874